HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Letizia Castelli Selected Research

incobotulinumtoxinA

10/2017Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Letizia Castelli Research Topics

Disease

8Multiple Sclerosis
10/2020 - 01/2017
2Fatigue
05/2024 - 10/2022
2Brain Injuries (Brain Injury)
03/2024 - 04/2022
1Sudden Infant Death (SID)
05/2024
1Deglutition Disorders (Dysphagia)
08/2023
1Stroke (Strokes)
10/2022
1Parkinson Disease (Parkinson's Disease)
11/2021
1COVID-19
01/2021

Drug/Important Bio-Agent (IBA)

4nabiximols (Sativex)IBA
01/2020 - 01/2017
3Dronabinol (THC)FDA LinkGeneric
10/2020 - 01/2019
2CannabidiolIBA
10/2020 - 01/2020
1VitaminsIBA
05/2024
1MineralsIBA
05/2024
1Biomarkers (Surrogate Marker)IBA
03/2024
1Dioctyl Sulfosuccinic Acid (DOSS)IBA
08/2023
14-Aminopyridine (4 Aminopyridine)FDA Link
01/2020
1cyclopropapyrroloindoleIBA
01/2018
1Botulinum Toxins (Botulinum Toxin)IBA
10/2017
1Type A Botulinum Toxins (Botox)FDA Link
10/2017
1incobotulinumtoxinAFDA Link
10/2017

Therapy/Procedure

5Therapeutics
05/2024 - 01/2019
2Cognitive Training
04/2022 - 11/2021
1Activities of Daily Living (ADL)
05/2024
1Physical Therapy Modalities (Physical Therapy Technique)
10/2022
1Deprescriptions
01/2021